<DOC>
	<DOCNO>NCT02250846</DOCNO>
	<brief_summary>The purpose study determine whether EGFR-TKI control development intracranial lesion Non Small Cell Lung Cancer patient asymptomatic brain metastasis , difference progression free survival exon 19 exon 21 mutation .</brief_summary>
	<brief_title>Study EGFR-TKI Asymptomatic Brain Metastases NSCLC</brief_title>
	<detailed_description>A open , positive control phase II clinical trial , divide selection period , treatment period follow-up period , comply standard set participant sign write informed consent , accord different divide 19 patient EGFR mutation outside show son mutation group ) 21 extra show mutation , accord ECOG physical status , age , previous systemic treatment hierarchical analysis , regular follow-up ass efficacy , life care safety .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Brain Neoplasms</mesh_term>
	<criteria>1. age 18 70 year old , male female 2. nonsmall cell lung cancer diagnose histopathology 3. detect ARMS confirm EGFR sensitive mutant patient 4. existence MRI diagnosis intracranial metastatic head enhancement , presence image evaluate lesion ( accord RECIST1.1 ) 5. receive prior treatment intracranial metastasis , include radiotherapy , gamma knife , chemotherapy drug 6. brain metastasis symptom , include , increase intracranial pressure , vomit , ignore papillary edema , headache , without hemiplegia , ignore thing clear , without epilepsy 7 . PS:0 1 8. expect survival time 3 month &amp; gt ; 9. patient sign informed consent voluntarily 1 . 4 week enter group receive operation operation , wound heal completely 2. group 2 week receive immune therapy treatment traditional Chinese Medicine 3. serious cardiovascular disease , include Department internal medicine , uncontrolled hypertension , unstable angina , myocardial infarction history exists within past June , severe arrhythmia pericardial effusion 4. serious infection , need intravenous antibiotic , antifungal antiviral treatment 5. enter group 4 week participate study drug clinical trial 6. serious tumor invasion , oppression main bronchus bronchial stenosis obstruction , superior vena cava syndrome 7. existence herniation brain tumor apoplexy , epilepsy , frequent 8. suffer mental illness , poor compliance 9. researcher think fit group case</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>EGFR mutation</keyword>
	<keyword>asymptomatic brain metastasis</keyword>
	<keyword>EGFR-TKI</keyword>
	<keyword>Erlotinib</keyword>
</DOC>